The importance of non-HDL cholesterol reporting in lipid management

Journal of Clinical Lipidology

Volumn 2, Issue 4, 2008, Pages 267-273

  Blaha, Michael J ^a   Blumenthal, Roger S ^a   Brinton, Eliot A ^b   Jacobson, Terry A ^c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Lipid management; Lipid panel reporting; Lipidology; Lipoproteins; Non HDL C

Indexed keywords

ANTILIPEMIC AGENT; BILE ACID SEQUESTRANT; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ATHEROGENESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DISEASE COURSE; DYSLIPIDEMIA; ELECTRON BEAM TOMOGRAPHY; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; HYPERTRIGLYCERIDEMIA; LABORATORY TEST; LIFESTYLE MODIFICATION; LIPID ANALYSIS; LIPID OXIDATION; METABOLIC SYNDROME X; MORTALITY; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK MANAGEMENT; RISK REDUCTION; STANDARDIZATION;

EID: 48549093490     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2008.06.013     Document Type: Review

References (33)

1. Brunzell J.D., Davidson M., Furberg C.D., Goldberg R.B., Howard B.V., et al. Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation. J Am Coll Cardiol 51 (2008) 1512-1524
2. Mudd J.O., Borlaug B.A., Johnston P.V., Kral B.G., Rouf R., Blumenthal R.S., and Kwiterovich Jr. P.O. Beyond low-density lipoprotein cholesterol: defining the role of low-density lipoprotein heterogeneity in coronary artery disease. J Am Coll Cardiol 50 (2007) 1735-1741
3. Otvos J.D., Jeyarajah E.J., and Cromwell W.C. Measurement issues related to lipoprotein heterogeneity. Am J Cardiol 90 suppl (2002) 22i-29i
4. Kwiterovich P.O. Clinical relevance of the biochemical, metabolic and genetic factors that influence low-density lipoprotein heterogeneity. Am J Cardiol 90 suppl (2002) 30i-45i
5. Adult Treatment Panel III. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA 285 (2001) 2486-2497
6. Mora S., Szklo M., Otvos J., et al. LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 192 (2007) 211-217
7. Austin M.A., King M.-C., Vranizan K.M., and Krauss R.M. Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk. Circulation 82 (1990) 495-506
8. Grundy S.M. Non-high-density lipoprotein cholesterol level as potential risk predictor and therapy target. Arch Intern Med 161 (2001) 1379-1380
9. Sarwar N., Danesh J., Eiriksdottir G., Sigurdsson G., Wareham N., et al. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation 115 (2007) 450-458
10. Liu J., Sempos C.T., Donahue R.P., Dorn J., Trevisan M., and Grundy S.M. Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease. Am J Cardiol 98 (2006) 1363-1368
11. Manninen V., Elo M.O., Frick M.H., et al. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA 260 (1988) 641-651
12. Abate N., Vega G.L., and Grundy S.M. Variability in cholesterol content and physical properties of lipoproteins containing apolipoprotein B-100. Atherosclerosis 104 (1993) 159-171
13. Ballantyne C.M., Andrews T.C., Hsia J.A., Kramer J.H., Shear C., and ACCESS Study Group. Atorvastatin Comparative Cholesterol Efficacy and Safety Study. Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: effect of 5 hydroxymethylglutaryl coenzyme A reductase inhibitors on non-high-density lipoprotein cholesterol levels. Am J Cardiol 88 (2001) 265-269
14. Garg A., and Grundy S.M. Management of dyslipidemia in NIDDM. Diabetes Care 13 (1990) 153-169
15. Frost P.H., and Havel R.J. Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy. Am J Cardiol 81 suppl (1998) 26B-31B
16. Sniderman A.D., Scantlebury T., and Cianflone K. Hypertriglyceridemic hyperapoB: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus. Ann Intern Med 135 (2001) 447-459
17. Sattar N., Williams K., Sniderman A.D., D'Agostino Jr. R., and Haffner S.M. Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis Study. Circulation 110 (2004) 2687-2693
18. Krauss R.M., and Siri P.W. Metabolic abnormalities: triglyceride and low-density lipoprotein. Endocrinol Metab Clin North Am 33 (2004) 405-415
19. Cui Y., Blumenthal R.S., Flaws J.A., Whiteman M.K., Langenberg P., et al. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 161 (2001) 1413-1419
20. Bittner V., Hardison R., Kelsey S.F., Weiner B.H., Jacobs A.K., Sopko G., and Bypass Angioplasty Revascularization Investigation. Non-high-density lipoprotein cholesterol levels predict five-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 106 (2002) 2537-2542
21. Lu W., Resnick H.E., Jablonski K.A., Jones K.L., Jain A.K., Howard W.J., Robbins D.C., and Howard B.V. Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the Strong Heart Study. Diabetes Care 26 (2003) 16-23
22. Liu J., Sempos C., Donahue R.P., Dorn J., Trevisan M., and Grundy S.M. Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes. Diabetes Care 28 8 (2005) 1916-1921
23. Ridker P.M., Rifai N., Cook N.R., Bradwin G., and Buring J.E. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 294 3 (2005) 326-333
24. Ingelsson E., Schaefer E.J., Contois J.H., McNamara J.R., Sullivan L., et al. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA 298 (2007) 776-785
25. Orakzai S.H., Nasir K., Blaha M., Blumenthal R.S., Raggi P., et al. Non-HDL cholesterol is strongly associated with coronary artery calcification in asymptomatic individuals. Atherosclerosis (2008) Mar 25. [Epub ahead of print.]
26. Kawamoto R., Oka Y., Tomita H., and Kodama A. Non-HDL cholesterol as a predictor of carotid atherosclerosis in the elderly. J Atheroscler Thromb 12 (2005) 143-148
27. Cromwell W.C., and Otvos J.D. Low-density lipoprotein particle number and risk for cardiovascular disease. Curr Atheroscler Rep 6 (2004) 381-387
28. Sniderman A.D., Furberg C.D., Keech A., et al. Apolipoproteins versus lipids as indices of coronary risk and as targets of statin treatment. Lancet 361 (2003) 777-780
29. Sacks F.M. The apolipoprotein story. Atherosclerosis 7 suppl (2006) 23-27
30. Lamarche B., Moorjani S., Lupien P.J., et al. Apolipoprotein A-1 and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec Cardiovascular Study. Circulation 94 (1996) 23-28
31. Walldius G., Jungner I., Holme I., Aastveit A.H., Kolar W., and Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 358 (2001) 2026-2033
32. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of low-density lipoprotein in plasma without use of preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
33. Davidson M.H., Maki K.C., Pearson T.A., Pasternak R.C., Deedwania P.C., et al. Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations. Am J Cardiol 96 (2005) 556-563